Longevity-focused investors-only conference announced

Latest articles

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

X marks the spot for meaningful information on aging and cognition

Understanding chromosomal differences between men and women could be the X Factor when it comes to tackling cognitive decline. A new paper published in Jama...

Most read

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Editor's picks

Peptide therapeutics company targets age-related disease

Gray Matter working with Insilico Medicine to identify peptide targets and accelerate development timeline for age-related disease therapies. Earlier this month, we brought you the...

Buck researchers provide a framework to study precision nutrigeroscience

One size doesn't fit all – a new research sub-specialty deals with the fact that health benefits from many forms of dietary restriction vary...

Accelerating antiaging research by hacking longevity

Bringing together aging researchers, developers and entrepreneurs, the Longevity Hackathon aims to build new tools, raise awareness and attract talent to the field. Kicking off...

Click the globe for translations.

The second investors-only conference focusing on longevity is set to take place on the 27th of September 2021.

The Longevity Investors Conference targets the global investor community and brings private and institutional investors from (U)HNWIs, Family Offices, VCs, Private Equity Funds, Private Banks and Asset Managers together with top class and longevity-experienced speakers.

Longevity.Technology: Longevity will be one of the largest, if not the largest, investment opportunity in the decades to come. Building on the success of last year’s conference, The Longevity Investors Conference aims to provide relevant insights into the subject, expert education and investment opportunities, not to mention excellent networking opportunities, and further cements Switzerland’s position as a longevity hotspot.

We’re also delighted to announce that our Founder and Editor-in-Chief Phil Newman will presenting an overview of longevity investment activity at the conference.

This year’s speaker selection includes outstanding individuals such as Dr Dina Radenkovic (Partner at Salt Bio Fund and Chief Scientific Officer at HOOKE), Sergey Young (Founder at Longevity Vision Fund), Dr Wei-Wu He (Executive Chairman, Human Longevity), Dr Brian Kennedy (Director at Centre for Healthy Ageing and Professor Departments of Biochemistry and Physiology at National University of Singapore), Michael Greve (Founder at Forever Healthy Foundation) and many more.

The conference is being organised by the two successful entrepreneurs and investors Dr Tobias Reichmuth (Founding Partner of Maximon AG, Founder of SUSI Partners and Chairman of Crypto Finance Group) and Marc P Bernegger (Founding Partner of Maximon AG and serial entrepreneur focusing on exponential technologies) who are also behind CfC St Moritz, the most exclusive conference for digital assets happening every year right before the World Economic Forum (WEF). In 2021 both entrepreneurs launched Maximon, a new company builder which aims to extend the healthspan and to allow humans to reach a fit, healthy and happy longevity.

Ovarian Longevity webinar

Longevity Investors Conference

The motivation for a second ‘Longevity Investors Conference’, says Dr Tobias Reichmuth is clear: “The longevity industry is highly attractive for investors. We state a lack of education and information for investors and want to change this. While there are scientific-oriented conferences, a professional and global investor focused longevity conference was missing which was shown by the big success of our first ‘Longevity Investors Conference’ last year.”

Marc P Bernegger adds: “The recent progress in radical life extension is very impressive and creates unique and massive investment opportunities. We see more and more traditional investors joining the space and our conference is a platform where leading aging scientists and longevity entrepreneurs meet high level investors from all over the world.”

The Longevity Investors Conference will take place on the 27th of September. The Conference usually takes place in St Moritz, Switzerland, however, as with so many events this year, due to Covid-19 it will be held as an online format in 2021.

Ovarian Longevity webinar

For more information about the conference, please visit www.longevityinvestors.ch or follow them on Twitter and LinkedIn.

Images courtesy of Longevity Investors Conference
Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.

Most popular

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

An antiaging supplement that also reduces appetite?

One for the AGEs: Juvify signs IP licensing deal with Buck Institute for GLYLO antiaging supplement that aims to reduce glycation. A researcher at the...

Berberine could be longevity’s “best-kept secret”

From tackling senescence to lowering blood sugar, berberine is the supplement with a host of tricks up its sleeves. Berberine is a bioactive compound found...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...

Related articles

SENS spin-out Underdog closes $10m financing round

Underdog Pharmaceuticals, a key investment of rejuvenation biotech VC Kizoo, has closed a $10 million round of capital. Michael Greve’s Kizoo Technology Capital Group led the...

Unlocking ovarian aging could prolong fertility and delay menopause

Ovarian aging is poorly understood, under-researched and under-invested. We need a radical rethink of how we address fertility and the menopause – it's time...

Occuity raises over £2.5m for optical diabetes devices

UK MedTech firm Occuity successfully raises over £2.5m to deliver ophthalmic and optical diabetes devices and is now overfunding on Seedrs to accelerate development. DISCLOSURE:...

Fauna closes $9 million to expand drug discovery platform

Leveraging animal genomics to improve human health, Fauna Bio set to expand its comparative genomics platform for novel target drug discovery. Silicon Valley biotech startup...

Targeting cognitive decline with medical food

Mitocholine raising funding for clinical trial of nutritional compound that addresses cognitive decline by bridging the ‘brain energy gap’. DISCLOSURE: Longevity.Technology (a brand of First...
Nutriop